TG Therapeutics | Betriebsaufwand





Betriebsaufwand Veränderung Datum
AbbVie USD 10.81B 13.45B 2025-12
Alaunos Therapeutics USD 1.19M 428K 2025-09
Amgen USD 5.9B 773M 2025-12
Ardelyx USD 105.66M 6.4M 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
Bayer EUR 10.2B 523M 2025-09
Biogen USD 1.88B 81.4M 2025-09
Corcept Therapeutics USD 197.64M 219K 2025-12
Curis USD -13.99M 7.38M 2025-06
Gilead Sciences USD 4.96B 707M 2025-12
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
J&J USD 18.97B 2.38B 2025-12
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Novartis USD 9.86B 115M 2025-09
Novavax USD 218.53M 34.86M 2024-09
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
TG Therapeutics USD 132.34M 26.04M 2025-09
Verastem USD 37.03M 8.97M 2024-09
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12


TG Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.